{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:41:01Z","timestamp":1792010461900,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T00:00:00Z","timestamp":1031097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/1471-2458-2-18","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Regular use of aspirin and pancreatic cancer risk"],"prefix":"10.1186","volume":"2","author":[{"given":"Ravi J","family":"Menezes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten B","family":"Moysich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,9,4]]},"reference":[{"key":"35_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/pmed.1995.1017","volume":"24","author":"LJ Marnett","year":"1995","unstructured":"Marnett LJ: Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med. 1995, 24: 103-6. 10.1006\/pmed.1995.1017.","journal-title":"Prev Med"},{"key":"35_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-4615-5325-0_53","volume":"400A","author":"MJ Thun","year":"1997","unstructured":"Thun MJ: Aspirin and gastrointestinal cancer. Adv Exp Med Biol. 1997, 400A: 395-402.","journal-title":"Adv Exp Med Biol"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q","volume":"82","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Louik C, Shapiro S: Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer. 1998, 82: 2326-33. 10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q.","journal-title":"Cancer"},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/sj.bjc.6690651","volume":"81","author":"JP Collet","year":"1999","unstructured":"Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L: Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer. 1999, 81: 62-8. 10.1038\/sj.bjc.6690651.","journal-title":"Br J Cancer"},{"key":"35_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers DM, Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994, 5: 138-46.","journal-title":"Epidemiology"},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","volume":"76","author":"EM Funkhouser","year":"1995","unstructured":"Funkhouser EM, Sharp GB: Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995, 76: 1116-9.","journal-title":"Cancer"},{"key":"35_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","volume":"7","author":"RE Harris","year":"1996","unstructured":"Harris RE, Namboodiri KK, Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 1996, 7: 203-5.","journal-title":"Epidemiology"},{"key":"35_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/pmed.1999.0518","volume":"29","author":"PF Coogan","year":"1999","unstructured":"Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S: The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med. 1999, 29: 72-6. 10.1006\/pmed.1999.0518.","journal-title":"Prev Med"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K","volume":"82","author":"D Zaridze","year":"1999","unstructured":"Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V: Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer. 1999, 82: 473-6. 10.1002\/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K.","journal-title":"Int J Cancer"},{"key":"35_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002, 94: 252-66. 10.1093\/jnci\/94.4.252.","journal-title":"J Natl Cancer Inst"},{"key":"35_CR11","first-page":"111","volume-title":"Eur J Surg Suppl","author":"DJ Ahnen","year":"1998","unstructured":"Ahnen DJ: Colon cancer prevention by NSAIDs: what is the mechanism of action?. Eur J Surg Suppl. 1998, 111-4. 10.1080\/11024159850191544."},{"key":"35_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0016-5085(98)70330-0","volume":"114","author":"RA Gupta","year":"1998","unstructured":"Gupta RA, DuBois RN: Aspirin, NSAIDS, and colon cancer prevention: mechanisms?. Gastroenterology. 1998, 114: 1095-8.","journal-title":"Gastroenterology"},{"key":"35_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1084\/jem.190.4.445","volume":"190","author":"SJ Shiff","year":"1999","unstructured":"Shiff SJ, Rigas B: The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med. 1999, 190: 445-50. 10.1084\/jem.190.4.445.","journal-title":"J Exp Med"},{"key":"35_CR14","first-page":"4356","volume":"59","author":"MA Molina","year":"1999","unstructured":"Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA: Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 1999, 59: 4356-62.","journal-title":"Cancer Res"},{"key":"35_CR15","first-page":"2018","volume":"5","author":"J Okami","year":"1999","unstructured":"Okami J, Yamamoto H, Fujiwara Y, Tsujie M, Kondo M, Noura S, Oshima S, Nagano H, Dono K, Umeshita K, Ishikawa O, Sakon M, Matsuura N, Nakamori S, Monden M: Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res. 1999, 5: 2018-24.","journal-title":"Clin Cancer Res"},{"key":"35_CR16","first-page":"987","volume":"59","author":"ON Tucker","year":"1999","unstructured":"Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 1999, 59: 987-90.","journal-title":"Cancer Res"},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF02781733","volume":"26","author":"T Koshiba","year":"1999","unstructured":"Koshiba T, Hosotani R, Miyamoto Y, Wada M, Lee JU, Fujimoto K, Tsuji S, Nakajima S, Doi R, Imamura M: Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int J Pancreatol. 1999, 26: 69-76. 10.1159\/000063508.","journal-title":"Int J Pancreatol"},{"key":"35_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/carcin\/21.2.139","volume":"21","author":"MT Yip-Schneider","year":"2000","unstructured":"Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ: Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis. 2000, 21: 139-46. 10.1093\/carcin\/21.2.139.","journal-title":"Carcinogenesis"},{"key":"35_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/00365520121464","volume":"36","author":"BP van Rees","year":"2001","unstructured":"van Rees BP, Ristimaki A: Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand J Gastroenterol. 2001, 36: 897-903. 10.1080\/003655201750305387.","journal-title":"Scand J Gastroenterol"},{"key":"35_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/carcin\/11.3.393","volume":"11","author":"M Takahashi","year":"1990","unstructured":"Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y: Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis. 1990, 11: 393-5.","journal-title":"Carcinogenesis"},{"key":"35_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1091-255X(00)80029-3","volume":"4","author":"RA Perugini","year":"2000","unstructured":"Perugini RA, McDade TP, Vittimberga FJ, Duffy AJ, Callery MP: Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines. J Gastrointest Surg. 2000, 4: 24-32. 10.1016\/S1091-255X(00)80029-3.","journal-title":"J Gastrointest Surg"},{"key":"35_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N","volume":"91","author":"A Kokawa","year":"2001","unstructured":"Kokawa A, Kondo H, Gotoda T, Ono H, Saito D, Nakadaira S, Kosuge T, Yoshida S: Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer. 2001, 91: 333-8. 10.1002\/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N.","journal-title":"Cancer"},{"key":"35_CR23","first-page":"4424","volume":"56","author":"K Subbaramaiah","year":"1996","unstructured":"Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ: Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 1996, 56: 4424-9.","journal-title":"Cancer Res"},{"key":"35_CR24","doi-asserted-by":"publisher","first-page":"14501","DOI":"10.1074\/jbc.272.23.14501","volume":"272","author":"LE Heasley","year":"1997","unstructured":"Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA: Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem. 1997, 272: 14501-4. 10.1074\/jbc.272.23.14501.","journal-title":"J Biol Chem"},{"key":"35_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","volume":"53","author":"C Almoguera","year":"1988","unstructured":"Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988, 53: 549-54.","journal-title":"Cell"},{"key":"35_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00000421-200110000-00007","volume":"24","author":"K Merati","year":"2001","unstructured":"Merati K, said Siadaty M, Andea A, Sarkar F, Ben-Josef E, Mohammad R, Philip P, Shields AF, Vaitkevicius V, Grignon DJ, Adsay NV: Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters. Am J Clin Oncol. 2001, 24: 447-52. 10.1097\/00000421-200110000-00007.","journal-title":"Am J Clin Oncol"},{"key":"35_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","volume":"85","author":"G Gridley","year":"1993","unstructured":"Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993, 85: 307-11.","journal-title":"J Natl Cancer Inst"},{"key":"35_CR28","first-page":"119","volume":"9","author":"PF Coogan","year":"2000","unstructured":"Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S: Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev. 2000, 9: 119-23.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"35_CR29","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Bmj. 2000, 320: 1642-6. 10.1136\/bmj.320.7250.1642.","journal-title":"Bmj"},{"key":"35_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/jnci\/94.15.1168","volume":"94","author":"KE Anderson","year":"2002","unstructured":"Anderson KE, Johnson TW, Lazovich D, Folsom AR: Association Between Nonsteroidal Anti-Inflammatory Drug Use and the Incidence of Pancreatic Cancer. J Natl Cancer Inst. 2002, 94: 1168-1171. 10.1093\/jnci\/94.15.1168.","journal-title":"J Natl Cancer Inst"},{"key":"35_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.2910430412","volume":"43","author":"C Mettlin","year":"1989","unstructured":"Mettlin C: Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer. 1989, 43: 608-12.","journal-title":"Int J Cancer"},{"key":"35_CR32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/oxfordjournals.aje.a115617","volume":"131","author":"C Mettlin","year":"1990","unstructured":"Mettlin C, Croghan I, Natarajan N, Lane W: The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol. 1990, 131: 973-83.","journal-title":"Am J Epidemiol"},{"key":"35_CR33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.aje.a115747","volume":"132","author":"C Mettlin","year":"1990","unstructured":"Mettlin C, Natarajan N, Huben R: Vasectomy and prostate cancer risk. Am J Epidemiol. 1990, 132: 1056-61.","journal-title":"Am J Epidemiol"},{"key":"35_CR34","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D","volume":"72","author":"O Suh","year":"1993","unstructured":"Suh O, Mettlin C, Petrelli NJ: Aspirin use, cancer, and polyps of the large bowel. Cancer. 1993, 72: 1171-7.","journal-title":"Cancer"},{"key":"35_CR35","first-page":"1","volume":"21","author":"TL Cornelison","year":"1997","unstructured":"Cornelison TL, Natarajan N, Piver MS, Mettlin CJ: Tubal ligation and the risk of ovarian carcinoma. Cancer Detect Prev. 1997, 21: 1-6.","journal-title":"Cancer Detect Prev"},{"key":"35_CR36","first-page":"725","volume-title":"In: Cancer epidemiology and prevention","author":"KE Anderson","year":"1996","unstructured":"Anderson KE, Potter JD, Mack T: Pancreas. In: Cancer epidemiology and prevention. Edited by: Schottenfeld D, Fraumeni Jr JF. 1996, New York (NY): Oxford University Press, 725-71. 2","edition":"2"},{"key":"35_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.pharmtox.42.082301.164620","volume":"42","author":"LJ Marnett","year":"2002","unstructured":"Marnett LJ, DuBois RN: COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol. 2002, 42: 55-80. 10.1146\/annurev.pharmtox.42.082301.164620.","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-2-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:36:01Z","timestamp":1726245361000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-2-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-2-18","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,4]]},"assertion":[{"value":"11 July 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}